What is the current price and volume for PHARM.AS stock?

PHARM.AS stock trades pre-market at **€1.71** with volume **22,173,820.00** shares versus average **17,430,073.00**, making it highly active on EURONEXT this session.

What valuation metrics should investors watch for PHARM.AS stock?

Watch PE (currently **-171.00**), P/S **3.93**, P/B **5.16**, and free cash flow yield **3.70%**. These show growth with stretched multiples for a biotech of this size.

What is Meyka AI's forecast for PHARM.AS stock?

Meyka AI's forecast model projects a 12‑month price of **€1.99** versus current **€1.71**, implying **16.20%** upside. Forecasts are model-based projections and not guarantees.

What catalysts could move PHARM.AS stock next?

Key catalysts include the **12 Mar 2026** earnings report, RUCONEST and Joenja revenue updates, regulatory news, and partnership announcements. Any guidance change will affect trading activity.

EU Stocks

Pre-market Most Active: PHARM.AS Pharming Group €1.71 29 Jan 2026: Volume rises

ByHuzaifa Zahoor January 29, 2026January 29, 2026

PHARM.AS stock opens pre-market at €1.71, down 3.93% on heavy activity that makes it one of the most active names on EURONEXT this morning. Volume is 22,173,820.00 shares versus an average of 17,430,073.00, pushing relative volume to 1.27. Traders are watching RUCONEST sales momentum and recent upward revisions in revenue guidance as catalysts. We track valuation and technical signals to show why PHARM.AS is drawing outsized flows in Europe ahead of the company’s next earnings announcement on 12 Mar 2026.